Novo Nordisk A/S Share Repurchase Programme Update

Novo Nordisk A/S announced an update on its share repurchase program. The company initiated a program on May 6, 2026, with the intention to repurchase B shares up to DKK 11,200,000,010.45 between May 6, 2026, and February 1, 2027. This is part of a larger DKK 15 billion repurchase program over a 12-month period starting February 4, 2026. Between June 8 and June 12, 2026, the company repurchased 1,125,000 B shares at an average price of DKK 273.58, totaling DKK 306,572,331. As of June 12, 2026, the total number of repurchased shares since the program began is 5,125,000, with a total transaction value of DKK 1,469,055,829. Novo Nordisk currently holds 37,069,480 B shares as treasury shares. Cumulatively, since February 4, 2026, the company has repurchased 19,884,179 B shares for a total value of DKK 5,269,055,819, at an average price of DKK 264.99 per share.